{"id":3919,"date":"2026-05-20T11:00:35","date_gmt":"2026-05-20T11:00:35","guid":{"rendered":"https:\/\/medtis.ch\/?p=3919"},"modified":"2026-09-14T10:59:52","modified_gmt":"2026-09-14T10:59:52","slug":"biomarkers26","status":"publish","type":"post","link":"https:\/\/medtis.ch\/en\/2026\/05\/20\/biomarkers26\/","title":{"rendered":"Beyond Chemotherapy: How Smart Drugs Are Reshaping Breast Cancer Treatment"},"content":{"rendered":"

Save the Date:<\/strong>
Wednesday, 30 September 2026 | 17:00 \u2013 18:15 <\/p>\n\n\n\n

Language: English<\/span><\/p>\n\n\n\n

\n
Registration<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

We are delighted to invite you to this webinar exploring the evolving role of precision medicine in the treatment of breast cancer.<\/p>\n\n\n\n

Chair
Prof. Dr. med. Jens Huober<\/strong>
HOCH Health Ostschweiz<\/p>\n\n\n\n

Rupert Bartsch, MD<\/strong>
Medical University of Vienne, Austia<\/p>\n\n\n\n

Prof. Dr. med. Zsuzsanna Varga<\/strong>
University Hospial Zurich, Switzerland<\/p>\n\n\n\n

Prof. Dr. med. Christian Kurzeder<\/strong>
University Hospial Base, Switzerland<\/p>\n\n\n\n

<\/div>\n\n\n\n

Programme<\/strong><\/p>\n\n\n\n

The program will provide insights into the growing importance of predictive factors and biomarkers<\/strong> for treatment decision-making, highlighting how accurate biological characterization of tumors enables a more personalized therapeutic approach. Participants will also gain an overview of the current landscape of antibody-drug conjugates (ADCs)<\/strong> and discuss key topics including treatment sequencing, emerging clinical evidence, and mechanisms of resistance.<\/p>\n\n\n\n

To translate science into practice, the webinar will conclude with an interactive patient case discussion<\/strong>, offering valuable perspectives on real-world decision-making and multidisciplinary management.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

CME credits<\/strong><\/p>\n\n\n\n

SGGG: 1 credit<\/p>\n\n\n\n

<\/div>\n\n\n\n

Join us for an engaging and clinically relevant discussion on how smart therapies are transforming outcomes for patients with breast cancer.<\/p>\n\n\n\n

Free participation is exclusively reserved for healthcare professionals and representatives of the industry sponsoring the webinar<\/strong>.<\/p>\n\n\n\n

Register now. We look forward to your participation.<\/strong><\/p>\n\n\n\n

\n
Registration<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

Free participation is exclusively reserved for healthcare professionals and representatives of the industry sponsoring the webinar<\/strong>.<\/p>\n\n\n\n

<\/div>\n\n\n\n